Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Litfulo is recommended for treating severe alopecia areata in people 12 and older, as it helps hair regrowth.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Promising cancer treatments were found, but the manufacturer closed.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Ruxolitinib can help regrow hair in severe alopecia areata.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.